Furthermore, expression levels of MLH1 and MSH2 (and of MSH6 only in initial tumors) were significantly associated with the Ki67 proliferation index in both initial and recurrent tumors, indicating a potential role of these proteins in GBM progression. This evidence concerns the gene MLH1 and glioblastoma.